Oxytocin is important to social behavior and emotion regulation in humans. Oxytocin's role derives in part from its effect on memory performance. More specifically, previous research suggests that oxytocin facilitates recognition of social (e.g., faces), but not of non-social stimuli (e.g., words, visual objects). We conducted the first within-subject study to this hypothesis in a double-blind, placebo-controlled design. We administered oxytocin (24 IU) and placebo (saline) in two separate sessions and in randomized order to healthy men. To obtain a baseline measure for session-dependent memory effects, which are caused by proactive interference, an additional group of male subjects in each session received placebo unbeknownst to them and the experimenter. After administration, participants studied faces and houses. Exactly one day after each study session, participants were asked to make memory judgments of new and old items. In the first study-test session, participants administered with oxytocin showed reduced recollection of previously studied faces and houses. Oxytocin also interacted with proactive-interference effects. By impeding memory in the first session, it reduced proactive interference in the second. But oxytocin contributed additionally to the memory-reducing effect of proactive interference when administered in the second session. These results demonstrate that oxytocin can have a memory-impairing effect on both social and non-social visual objects. The present study also emphasizes the necessity of including a non-treated, baseline group in within-subject designs when investigating oxytocin's effects on human memory.
Introduction
Oxytocin's dual functions as a central neurotransmitter and a peripheral hormone, however, do not have a direct relationThe neuropeptide oxytocin is important for learning, memory, ship (MacDonald and MacDonald, 2010) . Central oxytocin reand behavioral regulation in nonhuman mammals and ceptors are found throughout the brain in many structures humans. Oxytocin is produced and released by the magnocelimportant for information processing and memory, including lular neurons of the paraventricular and supraoptic nuclei of the hippocampus, amygdala, striatum, hypothalamus, nuclethe hypothalamus. It is also synthesized in peripheral tissues us accumbens, and midbrain (Gimpl and Fahrenholz, 2001 ). like the placenta, uterus, corpus luteum, testis, and heart.
The role that oxytocin plays in these central nervous regions B R A I N R E S E A R C H 1 4 5 1 ( 2 0 1 2 ) 6 5 -7 3 has been investigated in nonhuman mammals for more than four decades (e.g., Insel, 2010; Lee et al., 2009, for review) . Research on human behavior has grown rapidly in recent years (see Fehm-Wolfsdorf and Born, 1991; Heinrichs and Domes, 2008; MacDonald and MacDonald, 2010 , for reviews) and shown that oxytocin affects human social behavior, emotion regulation, social cognition, and memory. The focus of the present study is on oxytocin's effect on memory, which has been found to be diverse in lab animals but especially in humans.
In lab animals, oxytocin facilitates social recognition, which is defined as a reduction in the time that is spent investigating a conspecific during the second encounter as compared to the first. The effects of oxytocin on social recognition in nonhuman mammals have been shown in two ways. First, oxytocin injections in various regions of the brain facilitated social recognition (Ferguson et al., 2002; Lee et al., 2009) . Second, knock-out animals that lack oxytocin genes required for the development of oxytocin receptors demonstrate a deficit in social recognition (Ferguson et al., 2000; Lee et al., 2009 ). This deficit can be temporarily restored by a single injection of oxytocin before the initial encounter of a conspecific (Ferguson et al., 2000) . However, not all studies on oxytocin and social recognition have confirmed oxytocin's memoryenhancing effect. Some studies have instead suggested an interaction of the oxytocin dose with memory (Bielsky and Young, 2004) . Other studies, which investigated types of memory other than social recognition (Bohus et al., 1978; De Wied et al., 1991; Dubrovsky et al., 2002; Engelmann et al., 1996; Wu & Yu, 2004) , reported both memory-facilitating and memoryimpairing effects, suggesting that the behavioral test type and the brain area under investigation modulate oxytocininduced effects (Engelmann et al., 1996) .
Oxytocin has also been shown to have diverse effects on memory in humans. It has been found to facilitate memory for faces, which are considered social stimuli (Guastella et al., 2008; Rimmele et al., 2009; Savaskan et al., 2008) . When administered before the study phase of a recognition memory experiment, oxytocin enhanced memory performance for faces and was therefore suggested to enhance memory-encoding processes (Guastella et al., 2008; Rimmele et al., 2009) . Savaskan et al. (2008) administered oxytocin directly after the study phase but 24 h before the test phase and still found a memory-enhancing effect. They therefore suggested that oxytocin might not only enhance encoding but also consolidation processes. These positive effects of oxytocin on face memory, however, have not been consistently found and might depend on the emotional expressions of the faces. For example, some studies reported no effect or a small memory-impairing effect of oxytocin on neutral (Bruins et al., 1992; Ferrier et al., 1980; Guastella et al., 2008) or happy faces (Savaskan et al., 2008) , whereas other studies did not find any dependency on emotional expressions (Rimmele et al., 2009) . Studies that used non-social stimuli (i.e., words) found either a memory-impairing effect or none at all (Bruins et al., 1992; Di Simplicio et al., 2009; FehmWolfsdorf et al., 1984 FehmWolfsdorf et al., , 1988 Ferrier et al., 1980; .
Based on the complex picture of oxytocin's effects on human memory it has been suggested that oxytocin might facilitate memory for social but not for non-social stimuli (Lee et al., 2009; Rimmele et al., 2009; Savaskan et al., 2008) . The only study that directly compared memory performance for faces and non-social, visual objects (Rimmele et al., 2009) , found a selective memory-enhancing effect for faces. But this result may have been influenced by the fact that the non-social condition, which consisted of houses, landscapes, and art sculptures, contained a heterogeneous set of items and was thus easier to remember than the homogenous face condition.
The aim of the present study was to investigate oxytocininduced effects on memory for faces and a homogenous non-social class of objects (houses). The study is the first to use a within-subject design to control for individual differences in general memory and other personality traits, which could potentially lead to group differences and thus confound drug/placebo effects in between-subject designs. As in some previous studies (Guastella et al., 2008; Rimmele et al., 2009 ), a remember/know paradigm was used to investigate the influence of oxytocin on the two proposed sub-processes of recognition memory: familiarity (i.e., an item feels familiar) and recollection (i.e., an item is remembered with details from the study episode) (Yonelinas, 2002) .
The double-blind, placebo-controlled study consisted of two study-test sessions for each participant. Please see Fig. 1 for a schematic of the experimental procedure. In each study session, oxytocin or placebo was administered. Drug/placebo administration was counterbalanced across sessions within subjects. After substance administration, participants were asked to study a series of faces and houses, which were Fig. 1 -Schematic of the experimental design and examples for stimuli. Group abbreviations refer to the administrated nasal spray (O for oxytocin, P for placebo) and indicate the order in which it was received (e.g., OP indicates that oxytocin was received in Study Session 1 and placebo in Study Session 2).
shown intermixed within blocks. Exactly 24 h after the study sessions, recognition memory was tested. Participants were shown studied and new items. For each item, they were asked to decide whether the stimulus was new, "familiar," or if they "recollect" it. Recollection was explained as remembering that an item is old and in addition retrieving details from the experience studying this item like a thought that came to mind during study. Familiarity was explained as being sure that an item is old but not being able to retrieve any details about the study episode. Exactly one week after the first study session, participant returned for their second studytest session, which followed the same procedure as the first. This time, participants received either oxytocin or placebo depending on their administration in the first study-test session (i.e., if they had received oxytocin first, they received placebo now).
The study was initially conducted such that subjects randomly received either oxytocin in the first study-test session and placebo in the second, or placebo in the first and oxytocin in the second. The results indicated that oxytocin-induced effects on memory performance were modulated by the studytest session in which oxytocin was administered. This was very likely due to interactions of oxytocin with proactive interference, which refers to the phenomenon whereby previously studied material (i.e., from the first study-test session) interferes with the learning of new material at a later point in time (i.e., in the second study-test session). The initial design with just two subject groups made it impossible to disentangle this interaction of oxytocin and proactive interference because it confounded the experimental factors drug/placebo with study-test session as seen in previous within-subject designs (Tops and Wijers, 2011; Wirth et al., 2011) . To elucidate the observed interaction of oxytocin with proactive interference, an additional subject group was included in the study. All participants in that group received placebo in both the first and second study-test session. But to maintain doubleblindness as well as the expectation of receiving oxytocin, this administration scheme was unknown to the subjects and the experimenter. The present study thus investigated not only how oxytocin influenced memory performance for social (faces) and non-social (houses) visual objects, but also the effects of a single administration of oxytocin within repeated study-test sessions that used novel social and nonsocial objects.
Results

Performance measurement
Raw "recollect" responses were interpreted as "recollected" hits (to old items) and false alarms (to new items). The raw "familiar" condition cannot be taken as a direct reflection of familiarity because these responses are contingent on nonrecollection. Using the so-called independent rememberknow procedure (IRK, Yonelinas, 2002) , familiarity hits and false alarms were calculated as the probability for responding "familiar" to an item provided that the item was not given a "recollect" response (i.e., for hit rates and false alarms, respectively, IRK "familiar"="familiar"/(1-"recollect")). Discrimination indices of recollection and familiarity were estimated separately as hits minus false alarms using "recollect" and IRK "familiar" responses. Qualitatively similar results were obtained using d′ rather than hits minus false alarms as a discrimination measure. Overall recognition-memory accuracy was assessed as d′ by summarizing "familiar" and "recollect" judgments into "old" responses. We also computed the response bias, c, using the sum of "familiar" and "recollect" judgments as "old" responses.
Statistical analysis
Effects of oxytocin and repeated study-test sessions were analyzed in mixed model analyses of variance (ANOVA) with repeated measures on the within-subject factors test session (1 and 2) and stimulus category (faces and houses) and the between-subject factor group (OP: oxytocin first/placebo second, PO: placebo first/oxytocin second, PP: placebo first/placebo second). For analyses of control variables, the same ANOVAs were calculated but the factor stimulus category was excluded. Post-tests that followed up on significant main effects or interactions were Bonferroni-corrected for multiple comparisons. Cohen's d or eta-squared (η 2 ), indicating the proportion (between 0-none and 1-all) of variance in the dependent variables accounted for by the variation in the independent variable, are provided for all analyses.
Control variables
None of the included control variables showed any systematic variation across the three experimental groups. No significant differences between the OP, PO, and PP groups were found in attention (accuracies and reaction times of the Continuous Performance Test, all ps > .48), wakefulness (wakefulness scale of the MDMQ, all ps > .20), or mood (positive and negative affect scales of the PANAS, all ps > .53), all of which were measured before drug/placebo administration and just before the peak of the oxytocin concentration (35 min after administration, Born et al., 2002) . No group differences were found for the frequencies or reaction times of attractiveness ratings to faces and houses in the study phase (all ps > .10). At the end of Test Session 2, subjects were unable to identify the order in which they had received oxytocin and placebo (p > .72) as indicated by a Χ 2 test. Table 1 shows memory performance for all three experimental groups in Test Sessions 1 and 2 as measured by d′, response bias c, hits and false alarms for "recollect" and IRK "familiarity" judgments as well as discrimination indices of recollection and familiarity measured as hits minus false alarms for "recollect" and IRK "familiar" judgments, respectively. A separate group × test session × stimulus category ANOVA was run on each of the dependent measures shown in Table 1 . Only significant effects are described below. Thus, any non-reported effects were not significant. In general, measures of recollection, discrimination index and hit rates, showed the most reliable effects. These results are highlighted in Figs. 2 and 3, respectively.
Memory performance
Memory performance was generally more accurate for aces than for houses. This was seen in all measures reported n Table 1 , Fs(1,13) > 21.8, ps < .001, η 2 s = 0.63, apart from hit ates of IRK "familiar" judgments.
Memory performance was also generally better in Test Sesion 1 than 2, which we attribute to proactive interference. his was seen in all measures reported in Table 1 , Fs(1,13) 7.5, ps < .05, η 2 s = 0.36, apart from the false alarms for "recolect" judgments and the hit rates of IRK "familiar" judgments. or measures of overall recognition (d′) and recollection (disrimination index and hit rates), this main effect of test sesion was further qualified by a stimulus category × test ession interaction, Fs(1,13) > 7.1, ps < .05, η 2 s = 0.35, which indiated that memory performance for faces but not for houses as systematically lower in Test Session 2. Memory performance marginally differed across the three xperimental groups for the discrimination index of recollecion, F(2,26) = 2.8, p = .08, η 2 = 0.18. These differences across roups were only significant in Test Session 1, F(2,26) = 6.4, s < .05, η 2 s = 0.33. In Test Session 1, participants who had reeived oxytocin (i.e., OP group) showed significantly less accuate recollection than participants who had received placebo i.e., the PO and PP groups, which did not differ from one anther, p > .36), F(1,13) = 12.3, p < .01, η 2 = 0.49, for the comparison f OP with PO and F(1,13) = 6.3, p < .05, η 2 = 0.33 for the comparson of OP with PP, respectively. Finally, memory performance, in particular recollection, as differently affected by repeated testing in the three expermental groups, indicated by a group × test session interaction ound for the discrimination index of recollection, F(2,26) = 8.4, < .01, η 2 = 0.39, and for hit rates of "recollect" judgments, (2,26) = 7.1, p < .01, η 2 = 0.35. These group differences in proacive interference between Test Session 1 and 2 are depicted n Figs. 4 and 5. Statistics are given for the discrimination ndex of recollection (Fig. 4) and hit rates of "recollect" judgents (Fig. 5) , respectively. Recollection performance declined etween Test Sessions 1 and 2 for the PO group, Fs(1,13) = 31.7
and 23.0, ps < .001, η 2 s = 0.71 and 0.64, and the PP group, Fs(1,13) = 5.3 and 7.7, ps < .05, η 2 s = 0.29 and 0.37, but not for the OP group, ps > .96 and .85. PO and PP also showed test session × stimulus category interactions, Fs(1,13) > 4.1, ps < .05, η 2 s > 0.22, respectively, but note that the three-way interactions category × test session × group were not significant in the overall ANOVAs. Recollection of faces, but not houses, was significantly reduced in the second test session as compared to the first for PO, ts(13) = 6.6 and 6.8, ps < .001, Cohen's ds = .82 and .72, and to a lesser extent for PP, ts(13) = 3.4 and (Figs. 4 and 5) . For the response bias, no main effects or interactions were found apart from the main effect of stimulus category reported above. Thus, neither oxytocin nor repeated testing influenced the response bias.
Discussion
This is the first double-blind, placebo-controlled, withinsubjects study to investigate the effects of oxytocin on recognition memory for homogenous groups of social (faces) and non-social (houses) stimuli, and the second study to directly contrast the effect of oxytocin on memory for social and non-social visual objects (following Rimmele et al., 2009 ). We found a moderate memory-impairing effect of oxytocin for both faces and houses. With regard to the two component-processes of recognition memory (Yonelinas, 2002), recollection but not familiarity was affected by oxytocin. Specifically, oxytocin lowered the correct and detailed recollection of previously studied (i.e., old) faces and houses but did not affect overall recognition discrimination (d′), response bias, familiarity, or memory judgments to new items. No differences in attention, wakefulness, or mood, which could explain the observed memory-related effects, were found following oxytocin and placebo administration. The observed moderate memory-impairing effect therefore appears to represent an influence of oxytocin on memory processes not specific to the social or non-social nature of the stimuli. Evidence for the memory-impairing effect was found in between-group as well as within-group analyses. For the discrimination index of recollection, trends for a main effect of group and a group × test session interaction were found. In the first test session, subjects who had received oxytocin (i.e., group OP) while studying faces and houses showed subsequently lower recollection, than subjects who were administered with placebo (i.e., groups PO and PP; Fig. 2 ). As with all between-subject analyses, it is possible that this difference between the subject groups was driven by individual differences in general memory such that the oxytocin-group might have had generally lower memory performance than the placebo-groups independent of oxytocin administration. Individual differences, however, cannot explain the present findings because oxytocin selectively influenced differences in memory performance between Test Session 1 and 2 (i.e., session effects). Session effects represent within-group comparisons and thus control for individual differences.
Session effects, found in the discrimination index of recollection and the hit rates for "recollect" judgments, provided further, within-subject evidence for the memory impairing effect of oxytocin. No significant session effects (Cohen's d of Fig. 4 -Effects of test session measured as performance in Test Session 1 minus Test Session 2 for the discrimination index of recollection (i.e., hits minus false alarms) for faces and houses for all three experimental groups (OP for oxytocin first/placebo second, PP for placebo in first and second session, PO for placebo first/oxytocin second). Error bars indicate standard error.
Fig. 5 -Effects of test session measured as performance in
Test Session 1 minus Test Session 2 for the hit rates of accurate "recollect" judgments for studied (i.e., old) faces and houses for all three experimental groups (OP for oxytocin first/placebo second, PP for placebo in first and second session, PO for placebo first/oxytocin second). Error bars indicate standard error. Fig. 3 -Hit rates of accurate "recollect" judgments for studied (i.e., old) faces and houses in Test Sessions 1 and 2 for all three experimental groups (OP for oxytocin first/placebo second, PP for placebo in first and second session, PO for placebo first/oxytocin second). Error bars indicate standard error.
0.21 and 0.20 for both the discrimination index of recollection that this is because faces in the present study had neutral or and hit rates for "recollect" judgments) were found for the OP weakly smiling expressions, which were shown to be associgroup, who received oxytocin in the first session. The largest ated with either no effect of oxytocin (Bruins et al., 1992 ; session effects (Cohen's d of 0.82 and 0.72, respectively) were Guastella et al., 2008; Savaskan et al., 2008) or a memoryfound for the PO group, who received oxytocin in the second impairing effect (Ferrier et al., 1980) . However, other studies session. The PP group never received oxytocin and represents have shown that oxytocin-induced effects do not depend on a baseline measure for the session effect. This group showed facial expressions (Rimmele et al., 2009) or that oxytocin can medium session effects (Cohen's d of 0.68 and 0.54, respecenhance memory for neutral (Savaskan et al., 2008) or happy tively), which were smaller than those of the PO group. 1 The faces (Guastella et al., 2008) . Differences in facial expressions present patterns of session effects (Figs. 4 and 5) suggest are thus not a sufficient explanation for the present that oxytocin can prevent proactive interference when admemory-impairing effects. ministered in the first study-test session (i.e., in the OP By finding a memory-impairing effect on both social and group). In this session, oxytocin impairs memory and leads non-social stimuli, the present study differs from Rimmele to fewer stored memory-representations. Subsequently, in et al., 2009 , the only other study that directly compared effects the second study-test session, less proactive interference is of oxytocin on memory for social and non-social stimuli. observed because the reduced number of memory representaKirsch et al. (2005), which investigated amygdala activation tions from the first study-test session interferes less with the to fearful faces and threatening scenes in a matching task, new learning material of the second study-test session. The also reported identical oxytocin-induced effects on social PP group, which never received oxytocin, showed a significant and non-social stimuli. Together with the present study, effect of proactive interference because stored memory reprethese findings suggest that the distinction between memory sentations from the first study-test session interfered with for social and non-social stimuli (Lee et al., 2009 ; Rimmele the learning of new material in the second session. Finally, et al., 2009; Savaskan et al., 2008) is not sufficient to explain the PO group showed the largest session effects because this the inconsistent findings of oxytocin-induced effects on group was not only affected by proactive interference (similarhuman memory. ly as the PP group) but also by the administration of oxytocin
The present moderate memory-impairing results are in acin the second study-test session, which further reduced cord with those studies that found no effect or a memorymemory performance (Figs. 4 and 5 ). This result cannot be impairing effect of oxytocin on both non-social and social explained by individual differences between PP and PO bestimuli (Bruins et al., 1992; Di Simplicio et al., 2009 ; Fehmcause both groups had similar memory performance in the Wolfsdorf et al., 1984 Wolfsdorf et al., , 1988 Ferrier et al., 1980 ; Heinrichs first session. Taken together, the observed session effects suget al., 2004) . The present results are also consistent with regest that oxytocin impaired memory, in the first session for ports of amnestic effects of oxytocin on consolidation and re-OP and in the second session for PO. For OP, it prevented protrieval in rats (Bielsky and Young, 2004; Bohus et al., 1978 ; active interference in the second study-test session. But for
De Wied et al., 1991; Dubrovsky et al., 2002) . It is outside the PO, it impeded memory performance in the second studyscope of this study to solve the apparent inconsistency of test session in addition to the impairing effect of proactive inoxytocin-induced effects on human memory. Future research ference as seen in PP.
on this issue should explore the multiple factors currently Possible mechanisms for the observed memory-impairing being discussed as possibly moderating the effects of oxytocin effect are the detrimental influences of oxytocin on the hippo- (Bartz et al., 2011; De Dreu et al., 2011; Ophir et al., 2009 ; campus and amygdala, both of which are involved in the recRodrigues et al., 2009), including such aspects of the individual ollection of social and non-social memories (Diana et al., 2007;  as sex, age, personality traits, ability differences, or genetic Spaniol et al., 2009) and which have been shown to be affected variations of the oxytocin receptor gene, as well as such asby oxytocin administration. In rats, for example, oxytocin inpects of the testing situation as stimulus sex, task difficulty, fusion into the ventricles induced long-term depression in time of day of testing, or task instructions. the dentate gyrus (Dubrovsky et al., 2002) . In humans, oxytoThe present study is the first to use a within-subject design cin administered as nasal spray is assumed to bind to recepto investigate the effects of oxytocin on recognition memory. tors in the amygdala, and thereby reduces amygdala activity Along with previous considerations about within-subject maand associative memory consolidation (Domes et al., 2007a, nipulations of drug/placebo administrations (Tops and Wijers, b; Heinrichs and Gaab, 2007; Kirsch et al., 2005; Pitman et al., 2011; Wirth et al., 2011) , the present study confirms the impor-1993). Animal studies also showed that the effects of oxytocin tance of including a control condition, in which subjects do on memory are mediated by the amygdala (Ferguson et al., not receive the drug, to be able to interpret possible interac-2001).
tions of the drug/placebo administration with repeated The present results of memory-impairing effects of oxytotesting. 2 This is especially important when memory perforcin on faces and houses differ from previous findings of mance is the dependent variable of interest because of the memory-enhancing effects for faces (Guastella et al., 2008; Rimmele et al., 2009; Savaskan et al., 2008) . It could be argued 2 In fact, a complete design would not only have involved an additional group that received placebo in both test sessions but also 1 For the discrimination index of recollection and hit rates for a group that would have received oxytocin in both sessions. In the "recollect" judgments, the session effects of the PP group were sigpresent study, we decided against this option for practical reanificantly smaller than those for the PO group, Fs (1,13) = 6.8 and sons. Thus, the investigation of effect of repeated administration 4.8, ps < .05, η known effect of proactive interference on memory. It is possiselected to receive oxytocin in the first study-test session ble to avoid the influence of proactive interference by using and placebo in the second. Another 14 men (aged between-subject designs. But, instead of generally dismissing 18-28 years, M = 22.1, SD = 3.2) received placebo in the first seswithin-subject designs for the study of drug effects on memosion and then oxytocin. Analysis of these two groups of subry, it may be advisable for future within-subject memoryjects indicated that oxytocin interacted with session effects experiments to decrease proactive inference by increasing likely caused by proactive interference. To further elucidate the inter-session interval. Still, within-subject designs with this finding, an additional group of 14 subjects (aged narrow intervals between study-test sessions appear to be es-18-28 years, M = 21.1, SD = 3.3) was run under exactly the pecially relevant for the study of drugs, like oxytocin, which same conditions (i.e., double-blind, two study-test sessions) have been considered as potential treatment for various psyas the two previous groups. This additional group, however, chiatric conditions , for review; Pitman received placebo in each session to obtain a baseline for the et al., 1993). Such treatments would be administered in an enproactive interference effects. To maintain double-blindness vironment that is comprised of repeated learning and testing as well as the expectation of receiving oxytocin, the adminissituations, for which within-subject designs might be a tration of placebo in each session was made unbeknownst to surrogate.
the subjects and experimenter. There were no significant age To conclude, the present study provided evidence both differences across the three groups (p > .56) or for any pairfrom between-subject and within-subject analyses that oxywise comparisons (p > .30) . No participant reported any adtocin can impair memory nonspecifically for social and verse side effects. non-social visual objects. The detailed recollection of previously studied faces and houses was found to be compro-
Stimuli
mised when items were learned under oxytocin. No evidence was found for an influence of oxytocin on familiar-360 grayscale Caucasian faces (Color FERET database, Phillips ity processes or memory judgments to new items (i.e., false et al., 2000) and 360 grayscale American houses (courtesy of alarms). This study also emphasizes the necessity of includAlumit Ishai, Ishai et al., 1999) were used as stimuli. Faces ing a non-treated, baseline group in within-subject designs were presented in an elliptic mask that hid hair, ears, and when investigating oxytocin's effects on human memory.
clothing (Fig. 1) . All faces had neutral or weakly smiling facial With the inclusion of this group, we were able to show that expressions. Half of the faces were female. 3 Houses were edioxytocin interacts with proactive interference and provided ted to show no background (i.e., sky or clouds; Fig. 1 ). In the further evidence for the memory-impairing effect of oxytocin first study-test session, 120 faces and 120 houses served as on faces and houses.
encoding material, and 60 faces and 60 houses served as distracters. In the second study-test session, the same numbers
Experimental procedure
of completely new stimuli were used. In a pilot study, a separate group of men (N = 26, M = 20.6, SD = 3.0 years) completed
Subjects
two recognition-memory experiments to determine the recognition difficulty of each item. Based on the pilot data, two sets of target and distracter stimuli were created for faces Forty-two healthy, young, right-handed, non-smoking adult and houses. All sets within a given stimulus category were exundergraduates from the University of Colorado Boulder actly matched for recognition difficulty. One set of stimuli was volunteered in this study. As in many previous oxytocin studused in the first study-test session for half of each of the three ies, females were excluded because of possible side effects groups of participants; the same set was used in the second and ethical considerations (Campbell, 2008; Guastella et al., study-test session for the other half of the participants. This 2008; Rimmele et al., 2009) . Studies that included male and feorder was reversed for the other set of stimuli. The order of male participants reported no sex differences in the effects of stimulus sets was also counterbalanced within all three oxytocin on various cognitive tasks including face memory groups of subjects. (e.g., Alvares et al., 2010; Guastella et al., 2009; Savaskan et al., 2008) . None of our participants had ever been diagnosed with any neurological, psychiatric, or medical illness or was 4.4. Procedure on any medication, as determined in a self-report interview by a trained experimenter. The study was approved by the InThe study consisted of two procedurally identical study-test stitutional Review Board and the Scientific Advisory Research sessions (Fig. 1) . The interval between study sessions was exCommittee of the University of Colorado and was conducted actly one week for all subjects. The delay between study and in accordance with the Declaration of Helsinki. All particitest sessions was exactly 24 h for all subjects. Study and test pants gave written informed consent and were paid for sessions were conducted between 9 am and 4 pm. Time of participation.
day of testing did not vary significantly across the three subject groups (all ps for pairwise comparisons > .52). Participants
Design
were instructed to abstain from beverages with caffeine or
In a placebo-controlled, double-blind, within-subject design, two study-test sessions were conducted for all subjects.14 3 No significant statistical effects or interactions of oxytocin men (aged 18-29 years, M = 22.3, SD = 3.4) were randomly with the sex of the stimulus face were found.
alcohol 24 h before the study days and to maintain a regular sleep-wake cycle two nights before and during the study days, with sleep periods between about 11 pm and 7 am. On the study days, participants received 24 IU of oxytocin (Syntocinon Spray; Novartis; three puffs per nostril; each puff with 4 IU of oxytocin) or a placebo (saline nasal spray, three puffs per nostril) intranasally. This dose of oxytocin was chosen because the same dose was used in previous studies on oxytocin's effects on memory (Di Simplicio et al., 2009; Guastella et al., 2008; Rimmele et al., 2009; Savaskan et al., 2008) . Forty minutes after administration, when central nervous oxytocin levels reached the plateau of their highest concentration (Born et al., 2002) , participants studied 120 faces and 120 houses intermixed in 12 blocks. To promote retention until the next day, the study list was repeated once in a different random order, yielding a total of 24 blocks. In each run, each picture was presented for 2 s on a light gray background in the middle of a 17-inch monitor. Participants were told to memorize all stimuli as well as possible and to make attractiveness ratings (1 = very unattractive to 7 = very attractive) on a computer keyboard to foster memory encoding. To keep the presentation time for all items constant, participants were instructed to respond after the stimulus had disappeared. One second after their response, the next stimulus was presented. The study experiment lasted about 45 min.
Possible oxytocin-related changes in attention (assessed with a computerized Continuous Performance Task, CPT), wakefulness (assessed with the wakefulness scale of an English version of the Multidimensional Mood Questionnaire, MDMQ, Steyer et al., 1997) , and mood (assessed with the Positive and Negative Affect Scale, PANAS, Watson et al., 1988) were tracked over the course of the study session. Measurements were taken right before drug/placebo administration and right before the start of the study lists (35 min after drug/placebo administration).
On the test days, exactly 24 h after each study session, participants returned to complete the recognition test. All 240 studied items, intermixed with 60 new faces and 60 new houses, were tested in 12 blocks. Each stimulus was presented for 2 s. The response options then appeared below the stimulus, and participants were asked, without time limit, to make memory judgments for each item by pressing the corresponding key on a computer keyboard. They were told to judge the items as "recollected" when they could remember the presented item together with specific details about learning this item in the study session (such as a thought that came to mind or something that happened in the room), as "familiar" when they knew they had seen the item in the study session but could not remember any details from the study episode, and as "new" when they thought they had never seen the item before (Rajaram, 1993; Woodruff et al., 2006) . Before the recognition experiment, participants practiced to make recollect/familiar judgments to verify, as judged by the experimenter, that they fully understood the differences between the meanings of these memory judgments.
A self-report questionnaire of the participants' beliefs about the order in which they had received oxytocin and placebo was completed at the end of the second recognition session.
